Erythrocytes: Erythropoiesis and Metabolic Activities

Erythrocytes

Introduction

  • The mature erythrocyte is characterized as:
    • A biconcave disc with a central pallor occupying the middle one-third of the cell.
    • Contains the respiratory protein hemoglobin, which facilitates oxygen-carbon dioxide transport.
    • Has a typical lifespan of 120 days, during which it can move easily through tissue capillaries and splenic circulation.
    • As the erythrocyte ages, cytoplasmic enzymes are catabolized, leading to increased membrane rigidity and eventual phagocytosis and destruction.

Erythropoiesis

General Overview

  • Definition: Erythropoiesis refers to the production of erythrocytes.
  • It involves differentiation from hematopoietic stem cells (HSC) to mature erythrocytes.
  • Occurs in erythroblastic islands, composed of:
    • Normoblasts (erythroblasts) clustered around an iron-rich macrophage.
      • The macrophage plays a pivotal role by providing iron for hemoglobin maturation and cytokines that aid normoblast maturation into functional erythrocytes.

Oxygen and Hemoglobin Production

  • Oxygen transport to tissues and carbon dioxide transport from tissues is accomplished by the heme pigment within hemoglobin, synthesized during erythrocyte maturation.
  • Essential substances for normal erythrocyte and hemoglobin production include:
    • Amino acids (proteins)
    • Iron
    • Vitamin B12
    • Vitamin B6
    • Folic acid (a member of the vitamin B complex)
    • Trace minerals cobalt and nickel
  • Note: Deficiencies in any of these substances may result in abnormal erythropoiesis.

Erythropoietin (EPO)

Production and Function

  • Source:
    • Erythropoietin (EPO) is produced primarily by the peritubular cells of the kidneys (80% to 90%).
    • The liver contributes 10% to 20% of total EPO production, especially in the developing fetus.
  • Blood levels of EPO are inversely related to tissue oxygenation:
    • Greater hypoxia corresponds to higher EPO levels.
  • EPO is classified as both an early-acting and late-acting cytokine, influencing:
    • BFU-E (Burst Forming Unit-Erythroid) and CFU-E (Colony Forming Unit-Erythroid) progenitors.
    • Erythroblastic precursors and interacts with IL-3, GM-CSF, IL-1, and TSF to facilitate maturation and differentiation of other cell types.

Additional Functions

  • Functions of EPO include:
    • Accelerating mRNA and protein synthesis, notably hemoglobin synthesis.
    • Reducing maturation time of metarubricytes (orthochromatophilic normoblasts; nRBCs).
    • Stimulating the premature release of immature RBCs (reticulocytes) from the bone marrow.
    • Enhancing the rate of enucleation (extrusion of an RBC nucleus).

Maturation and Development of Erythrocytes

Process Overview

  • Erythroid cell differentiation from stem cells requires 4 to 5 days of maturation through various nucleated cell stages.
  • Bone marrow reticulocytes mature in an average of 2.5 days.
  • Upon entering the bloodstream, reticulocytes remain in that stage for approximately 1 day.
  • Reticulocytes constitute about 0.5% to 1.5% of circulating erythrocytes.

Stages of Erythrocyte Development

  • Development progresses through distinct stages:
    • Pronormoblast (Rubriblast)
    • Basophilic Normoblast (Prorubricyte)
    • Polychromatophilic Normoblast (Rubricyte)
    • Orthochromic Normoblast (Metarubricyte)
    • Polychromatin Erythrocyte (Reticulocyte)
    • Mature Red Blood Cell (Mature Erythrocyte)

Metarubricytes

  • Size: 8-12 μm
  • Nucleus:
    • Chromatin pattern is tightly condensed.
  • Cytoplasm:
    • Appears reddish-pink (acidophilic).

Reticulocytes

Characteristics

  • Utilizes a supravital stain (e.g., new methylene blue) to visualize ribosomal RNA, which forms a deep-blue, mesh-like network.
  • The reticulocyte count is a standard clinical laboratory procedure indicating erythrocyte production rates.

Disorders Related to Erythrocyte Maturation and Production

Erythropoietin Disorders

  • Polycythemia: refers to an elevated concentration of erythrocytes (erythrocytosis) exceeding normal levels for age and gender.
    • Types:
    • Secondary (absolute) polycythemias arise from increased EPO production; they are distinguished from polycythemia vera and relative polycythemias.
      • Mechanisms leading to secondary polycythemia include:
      • High oxygen affinity hemoglobin
      • Chronic lung diseases
      • Smoking
      • High altitude living

Increased Red Cell Production

  • Erythrocyte increases can arise from non-EPO-related conditions, hence termed relative polycythemias.
    • Relative polycythemia typically correlates with plasma volume reduction (e.g., dehydration), which can make hematocrit levels appear elevated inaccurately.

Defective Nuclear Maturation

  • Megaloblastic maturation characterized by disparities between nuclear and cytoplasmic maturation seen in anemias (like vitamin B12 or folate deficiencies).
    • Observable effects include:
    • Nuclear maturation lags behind cytoplasmic maturation due to an impaired capacity to synthesize DNA; interphase and mitotic phases are prolonged.
    • This asynchronous maturation can be misleading as nuclear development appears younger than what the cytoplasmic maturity indicates.

Metabolic Activities of Erythrocytes

General Metabolic Characteristics

  • Mature erythrocytes lack a nucleus and organelles but can survive in the blood for about 120 days.
  • Limited metabolism of fatty acids and amino acids due to the absence of mitochondria.
  • Energy is primarily derived from anaerobic glycolysis via the Embden-Meyerhof-Parnas pathway, with additional support from:
    • Hexose monophosphate shunt
    • Methemoglobin reductase pathway
    • Luebering-Rapoport pathway

Membrane Characteristics of Erythrocytes

Aging and Membrane Stability

  • Changes in cell membrane properties can be monitored through:
    • Plasma membrane calcium (PMCA) and glycated hemoglobin (Hgb A1C).
      • PMCA strength decreases as the RBC ages.
      • Hgb A1C levels rise with age, leading to membrane densification contributing to instability in senescent RBCs.

Erythrocytic Enzyme Deficiencies

  • Two common enzyme deficiencies that affect the Embden-Meyerhof-Parnas pathway include:
    • Glucose-6-Phosphate Dehydrogenase (G6PD)
    • Function: Converts glucose-6-phosphate (G6P) to 6-phosphogluconate (6PG).
    • Pyruvate Kinase (PK)
    • Function: Converts pyruvate (pyruvic acid) to lactic acid.